1. Sawabe T, Ogura Y, Matsumura Y, et al. Updating the Vibrio clades defined by multilocus sequence phylogeny: proposal of eight new clades, and the description of Vibrio tritonius sp. nov.
Front Microbiol 2013 Dec 27; 4: 414. doi: 10.3389/fmicb.2013.00414. Erratum in: Front Microbiol 2014; 5: 583.
2. Dutta D, Kaushik A, Kumar D and Bag S. Foodborne Pathogenic Vibrios: Antimicrobial Resistance. Front Microbiol 2021; 12: 638331. doi: 10.3389/fmicb.2021.638331.
3. Waldor MK, Ryan ET. Chapter 214, Vibrio cholerae. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9th ed. Philadelphia,
PA: Elsevier; 2020: pages 2636-2644.e2.
4. Neill MA. Chapter 215, Other Pathogenic Vibrios. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9th ed. Philadelphia,
PA: Elsevier; 2020: pages 2645-2649.e1.
5. Murray PR, Rosenthal KS, Pfaller MA. Chapter 26, Vibrio and Related Bacteria. In: Medical Microbiology Ninth edition Elsevier; 2021: 271-277.e1.
6. Sack DA, Sack RB, Nair GB, Siddique AK. Cholera. Lancet 2004; 363: 223-233.
7. Abbott SL, Janda JM, Johnson JA, and Farmer III JJ. Chapter 47. Vibrio and Related Organisms. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, (eds). Manual of Clinical
Microbiology, 9th ed. Washington DC: ASM Press, 2007: 723-733.
8. Tille PM. Chapter 26. Vibrio, Aeromonas, Chromobacterium, and Related Organisms. In: Bailey & Scott’s Diagnostic Microbiology. Thirteenth Edition. Elsevier, Mosby. 2014: 367-375.
9. Ali M, Nelson AR, Lopez AL, Sack DA. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis 2015 Jun 4;9(6):e0003832. doi: 10.1371/journal.pntd.0003832.
10. www.who.int/health-topics/cholera
11. Kanungo S, Azman AS, Ramamurthy T, Deen J, Dutta S. Cholera. Lancet 2022 Apr 9;399(10333):1429-1440. doi: 10.1016/S0140-6736(22)00330-0.
12. www.cdc.gov/cholera/index.html
13. Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB. Cholera. Lancet 2012; 379: 2466-2476. doi: 10.1016/S0140-6736(12)60436-X.
14. Öngen B. Bölüm 74. Vibrio cholerae Enfeksiyonlarında Patogenez. İç: Enfeksiyon Patogenezi ve Bağışıklık. Badur S, Abacıoğlu H, Öngen B (eds). 1. baskı İstanbul, Akademi Yayınevi, 2015:
sayfalar 965-981.
15. Safa A, Nair GB, Kong RY. Evolution of new variants of Vibrio cholerae O1. Trends in Microbiology Jan 2010; 18(1): 46-54.
16. Ertem B. İstanbul Sağmalcılar Kolera Salgını. Gaziantep University Journal of Social Sciences (1970) 2020; Special Issue : 647-660.
17. Banerjee R, Das B, Nair GB, Basak S. Dynamics in genome evolution of Vibrio cholerae. Review. Infection, Genetics and Evolution 2014; 23: 32-41.
18. Takeda Y. Vibrio parahaemolyticus, enterotoxigenic Escherichia coli, enterohemorrhagic Escherichia coli and Vibrio cholerae. Proc Jpn Acad Ser B Phys Biol Sci 2011; 87(1): 1-12.
19. Megraud F, Musso D, Drancourt M, Lehours P. Chapter 182. Curved and Spiral Bacilli. In: Cohen J, Powderly WG, Opal SM, (eds). Infectious Disease. 4th ed. London: Elsevier, 2017: 1600-
1610.e2.
20. Islam MS, Zaman MH, Islam MS, Ahmed N, Clemens JD. Environmental reservoirs of Vibrio cholerae. Vaccine 2020 Feb 29; 38 Suppl 1: A52-A62.
21. Mohammed Y, Aboderin AO, Okeke IN, Olayinka AT. Antimicrobial resistance of Vibrio cholerae from sub-saharan Africa: A systematic review. African Journal of Laboratory Medicine 2018;
7(2): a778.
22. Okeke IN, Aboderin OA, Byarugaba DK, Ojo KK, Opintan JA. Growing problem of multidrug-resistant enteric pathogens in Africa. Emerg Infect Dis 2007 Nov; 13(11): 1640-1646. doi:
10.3201/eid1311.070674.
23. Chac D, Dunmire CN. Singh J, Weil AA. Update on Environmental and Host Factors Impacting the Risk of Vibrio cholerae Infection. ACS Infect Dis 2021; 7: 1010-1019.
24. Chapter 8. Curved Gram-Negative Bacilli and Oxidase-Positive Fermenters. Pages 432-472. Phylogeny of the Vibrionaceae (pages 449-457). Procop GW, Church DL, Hall GS, Janda WM, Ko-
neman EW, Schreckenberger PC, Woods GL. (editors). Koneman’s Color Atlas and Textbook of Diagnostic Microbiology. Seventh edition. 2017. Janes & Barlett Learning. Lippincott Williams
and Wilkins. Wolters Kluwer.
25. Ramamurthy T, Das B, Chakraborty S, Mukhopadhyay AK, Sack DA. Diagnostic techniques for rapid detection of Vibrio cholerae O1/O139. Vaccine 2020; 38: A73–A82. doi: 10.1016/j.vacci-
ne.2019.07.099.
26. Mandal S, Mandal MD, Pal NK. Cholera: a great global concern. Asian Pac J Trop Med 2011 Jul; 4(7); 573-580.
27. Mutreja A, Kim DW, Thomson NR, et al. Evidence for several waves of global transmission in the seventh cholera pandemic. Nature 2011 Aug 24; 477(7365): 462-465. doi: 10.1038/natu-
re10392.
28. Pant A, Das B, Bhadra RK. CTX phage of Vibrio cholerae: Genomics and applications. Vaccine 2020; 38: A7-A12.
29. Kumar A, Das B, Kumar N. Vibrio Pathogenicity Island-1: The Master Determinant of Cholera Pathogenesis. Front Cell Infect Microbiol 2020 Oct 6; 10: 561296. doi:10.3389/fcimb.2020.561296.
30. Kim EJ, Lee D, Moon SH, Lee CH, Kim DW. CTX prophages in Vibrio cholerae O1 strains. J Microbiol Biotechnol 2014 Jun 28; 24(6): 725-31. doi: 10.4014/jmb.1403.03063.
31. Waldor MK, Tschäpe H, Mekalanos JJ. A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139. J Bacteriol 1996
Jul; 178(14): 4157-4165. doi: 10.1128/jb.178.14.4157-4165.1996.
32. Hartley DM, Morris JG Jr, Smith DL. Hyperinfectivity: a critical element in the ability of V. cholerae to cause epidemics? PLoS Med 2006 Jan; 3(1): e7. doi: 10.1371/journal.pmed.0030007. Epub
2005 Dec 6.
33. Weil AA, Ryan ET. Cholera: recent updates. Curr Opin Infect Dis 2018 Oct; 31(5): 455-461. doi: 10.1097/QCO.0000000000000474.
34. Merrell DS, Butler SM, Qadri F, et al. Host-induced epidemic spread of the cholera bacterium. Nature 2002 Jun 6; 417(6889): 642-645. doi: 10.1038/nature00778.
35. Sugimoto JD, Koepke AA, Kenah EE, et al. Household Transmission of Vibrio cholerae in Bangladesh. PLoS Negl Trop Dis 2014; 8(11): e3314.
36. Deen J, Mengel MA, Clemens JD. Epidemiology of cholera. Vaccine 2020 Feb 29; 38 Suppl 1: A31-A40. doi: 10.1016/j.vaccine.2019.07.078. Epub 2019 Aug 5.
37. Deen JL, von Seidlein L, Sur D, et al. The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa. PLoS Negl Trop Dis. 2008 Feb 20; 2(2): e173.
doi: 10.1371/journal.pntd.0000173.
38. Harris JB, LaRocque RC, Charles RC, Mazumder RN, Khan AI, Bardhan PK. Cholera’s western front. Lancet 2010; 376: 1961–1965.
39. Harris JB, LaRocque RC, Chowdhury F, et al. Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl Trop Dis 2008; 2:
e221.
40. Perez-Reytor D, Jana V, Pavez L, Navarrete P and Garcia K. Accessory Toxins of Vibrio Pathogens and Their Role in Epithelial Disruption During Infection. Front in Microbiol 2018 Sep 20;
9: 2248. doi: 10.3389/fmicb.2018.02248.
41. Kuhlmann FM, Santhanam S, Kumar P, et al. Blood Group O-Dependent Cellular Responses to Cholera Toxin: Parallel Clinical and Epidemiological Links to Severe Cholera. Am J Trop Med
Hyg 2016; 95:440.
42. LaRocque R, Harris JB. Cholera: Clinical features, diagnosis, treatment, and prevention. UpToDate. Calderwood SB (section ed), Baron EL (deputy ed.) – last updated Jan 29, 2023.
43. LaRocque R, Harris JB. Cholera: Microbiology and Pathogenesis. UpToDate. Calderwood SB (section ed), Baron EL (deputy ed.) – last updated Apr 13, 2023.
44. Clemens JD, Nair GB, Ahmed T, et al. Cholera. Lancet 2017 Sep 23; 390(10101):1539-1549. doi: 10.1016/S0140-6736(17)30559-7.
45. Khan AI, Chowdhury F, Leung DT, et al. Cholera in pregnancy: Clinical and immunological aspects. Int J Infect Dis 2015 Oct; 39:20-24. doi: 10.1016/j.ijid.2015.08.006.
46. Montero DA, Vidal RM, Velasco J, et al. Vibrio cholerae, classification, pathogenesis, immune response, and trends in vaccine development. Front Med (Lausanne). 2023 May 5; 10: 1155751.
doi: 10.3389/fmed.2023.1155751.
47. Aktar A, Rahman MA, Afrin S, et al. Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection
among household contacts of cholera patients in Bangladesh. PLoS Negl Trop Dis 2018; 12: 1–15. doi: 10.1371/journal.pntd.0006399.
48. Leibovici-Weissman Y, Neuberger A, Bitterman R, Sinclair D, Salam MA, Paul M. Antimicrobial drugs for treating cholera. Cochrane Database Syst Rev. 2014 Jun 19;2014(6):CD008625. doi:
10.1002/14651858.CD008625.pub2.
49. Kaushik JS, Gupta P, Faridi MM, Das S. Single dose azithromycin versus ciprofloxacin for cholera in children: a randomized controlled trial. Indian Pediatr 2010 Apr; 47(4):309-315. doi:
10.1007/s13312-010-0059-5.
50. Chowdhury F, Ross AG, Islam MT, McMillan NAJ, Qadri F. Diagnosis, Management, and Future Control of Cholera. Clin Microbiol Rev 2022 Sep 21; 35(3): e0021121. doi: 10.1128/cmr.00211-
21.
51. Cholera vaccines: WHO position paper – August 2017. Wkly Epidemiol Rec. 2017 Aug 25; 92(34): 477-498.
52. Ray A, Sarkar K, Haldar P, Ghosh R. Oral cholera vaccine delivery strategy in India: Routine or campaign?—A scoping review. Vaccine 2020 Feb 29; 38 Suppl 1: A184-A193. doi:10.1016/j.
vaccine.2019.07.082.
53. Bhattacharya SK, Sur D, Ali M, et al. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet
Infect Dis 2013; 13: 1050–1056.
54. Gabutti G, Rossanese A, Tomasi A, et al. Cholera, the Current Status of Cholera Vaccines and Recommendations for Travellers. Vaccines (Basel) 2020 Oct 14; 8(4):606. doi: 10.3390/vacci-
nes8040606.
55. Collins JP, Ryan ET, Wong KK, et al. Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022. MMWR Recomm Rep 2022 Sep 30; 71(2): 1-8. doi:
10.15585/mmwr.rr7102a1.
56. Baker-Austin C, Oliver JD, Alam M, et al. Vibrio spp. infections. Nat Rev Dis Primers 2018 Jul 12; 4(1):8. doi: 10.1038/s41572-018-0005-8. Erratum in: Nat Rev Dis Primers 2021 Feb 19; 7(1):
15.
57. Li G, Wang MY. The role of Vibrio vulnificus virulence factors and regulators in its infection-induced sepsis. Folia Microbiol (Praha) 2020 Apr; 65(2): 265-274. doi: 10.1007/s12223-019-00763-
7.
58. Pavia AT, Bryan JA, Maher KL, Hester TR Jr, Farmer JJ 3rd. Vibrio carchariae infection after a shark bite. Ann Intern Med 1989 Jul 1; 111(1):85-86. doi: 10.7326/0003-4819-111-1-85